BIOVIE INC -30 (BIVIW:NASDAQ)
$0.263 0.0631 (31.5658%)
Analysed BIOVIE INC -30 (BIVIW:NASDAQ) News Sources
BioVie CEO explains Bezisterim Parkinson’s trial results - ICYMI
11-04-2026
proactiveinvestors.com
BioVie targets neuroinflammation and insulin resistance in Parkinson’s treatment approach
09-04-2026
yahoo.com
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
02-04-2026
yahoo.com
BioVie to present Parkinson’s study data at AD/PD 2026 conference
12-03-2026
proactiveinvestors.com
BioVie Announces Abstract Accepted for Presentation at AD/PD 2026
12-03-2026
yahoo.com
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
27-02-2026
yahoo.com
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on March 4
23-02-2026
yahoo.com
New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America
21-02-2026
yahoo.com
BioVie highlights bezisterim research at ACP meeting
12-02-2026
proactiveinvestors.com
BioVie Announces Abstracts Accepted for Presentation at the 2026 American College of Psychiatrists Annual Meeting
12-02-2026
yahoo.com
What is the current price of BIOVIE INC -30 (BIVIW:NASDAQ)?
The current price of BIOVIE INC -30 (BIVIW:NASDAQ) is $0.263.
BIOVIE INC -30 (BIVIW:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOVIE INC -30 (BIVIW:NASDAQ) since the previous trading day is $0.0631.
BIOVIE INC -30 (BIVIW:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOVIE INC -30 (BIVIW:NASDAQ) since the previous trading day is 31.5658%.
What is the most recent average sentiment score for BIOVIE INC -30 (BIVIW:NASDAQ)?
The most recent average sentiment score for BIOVIE INC -30 (BIVIW:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for BIOVIE INC -30 (BIVIW:NASDAQ)?
The most recent sentiment for BIOVIE INC -30 (BIVIW:NASDAQ) is .
SEC-8K** Filing Available For BIOVIE INC -30 (BIVIW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.